Risk factors of central nervous system relapse in mantle cell lymphoma

References

• Swerdlow S, Campo E, Seto M, et al. Mantle cell lymphoma. In: Swerdlow S, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008. pp. 229–232.
   Google Scholar
• Pérez-Galán P, Dreyling M, Wiestner A. Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era. Blood 2011;117:26–38.
   PubMed Web of Science ®Google Scholar
• Bertoni F, Rinaldi A, Zucca E, et al. Update on the molecular biology of mantle cell lymphoma. Hematol Oncol 2006;24:22–27.
   PubMed Web of Science ®Google Scholar
• Zucca E, Roggero E, Pinotti G, et al. Patterns of survival in mantle cell lymphoma. Ann Oncol 1995;6:257–262.
   PubMed Web of Science ®Google Scholar
• Ghielmini M, Zucca E. How I treat mantle cell lymphoma. Blood 2009;114:1469–1476.
   PubMed Web of Science ®Google Scholar
• van Besien K, Gisselbrecht C, Pfreundschuh M, et al. Secondary lymphomas of the central nervous system: risk, prophylaxis and treatment. Leuk Lymphoma 2008;49(Suppl. 1):52–58.
   PubMed Web of Science ®Google Scholar
• Doolittle ND, Abrey LE, Shenkier TN, et al. Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group report. Blood 2008;111:1085–1093.
   PubMed Web of Science ®Google Scholar
• Ferreri AJM, Assanelli A, Crocchiolo R, et al. Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options. Hematol Oncol 2009;27:61–70.
   PubMed Web of Science ®Google Scholar
• Oinonen R, Franssila K, Elonen E. Central nervous system involvement in patients with mantle cell lymphoma. Ann Hematol 1999;78:145–149.
   PubMed Web of Science ®Google Scholar
• Montserrat E, Bosch F, Lopez-Guillermo A, et al. CNS involvement in mantle-cell lymphoma. J Clin Oncol 2002;14:941–944.
   Google Scholar
• Ferrer A, Bosch F, Villamor N, et al. Central nervous system involvement in mantle cell lymphoma. Ann Oncol 2008;19:135–141.
   PubMed Web of Science ®Google Scholar
• Gill S, Herbert KE, Prince HM, et al. Mantle cell lymphoma with central nervous system involvement: frequency and clinical features. Br J Haematol 2009;147:83–88.
   PubMed Web of Science ®Google Scholar
• Cheah C, George A, Gine E, et al. Incidence, characteristics and outcome of CNS involvement in mantle cell lymphoma: a multicenter retrospective analysis from the European Mantle Cell Lymphoma Network. Haematologica 2012;97(Suppl. 1):Abstract 1112.
   Google Scholar
• The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993;329:987–994.
   PubMed Web of Science ®Google Scholar
• Hoster E, Dreyling M, Klapper W, et al. A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. German Low Grade Lymphoma Study Group (GLSG); European Mantle Cell Lymphoma Network. Blood 2008;111:558–565.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999;17:1244–1253.
   PubMed Web of Science ®Google Scholar
• Altman DG, De Stavola BL, Love SB, Stepniewska KA. Review of survival analyses published in cancer journals. Br J Cancer 1995; 72:511–518.
   PubMed Web of Science ®Google Scholar
• Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457–481.
   Web of Science ®Google Scholar
• Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley & Sons; 1980.
   Google Scholar
• Cox DR. Regression models and life tables. J R Stat Soc 1972;34: 187–220.
   Google Scholar
• Gill S, Seymour JF. What is the real risk of central nervous system involvement in mantle cell lymphoma?Leuk Lymphoma 2008;49: 2237–2239.
   PubMed Web of Science ®Google Scholar
• Gatt ME, Grisaro S. Central nervous system prophylaxis in mantle cell lymphoma. Blood 2009;114:5402–5403; author reply 5403–5404.
   PubMed Web of Science ®Google Scholar
• Feugier P, Virion JM, Tilly H, et al. Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab. Ann Oncol 2004;15:129–133.
   PubMed Web of Science ®Google Scholar
• Matutes E, Parry-Jones N, Brito-Babapulle V, et al. The leukemic presentation of mantle-cell lymphoma: disease features and prognostic factors in 58 patients. Leuk Lymphoma 2004;45:2007–2015.
   PubMed Web of Science ®Google Scholar